Identification of adipose tissue-related predictors of the reduction in cardiovascular risk induced by metabolic surgery.
Alberto Melchor-LópezJuan Antonio Suárez-CuencaDiana Zaineff Banderas-LaresGustavo De la Peña-SosaMoisés Salamanca-GarcíaEduardo Vera-GómezAlejandro Hernández-PatricioJuan Ariel Gutiérrez-BuendíaCarlos Ramiro Zamora-AlemánSofía Lizeth Alcaráz-EstradaMoisés Ortiz-FernándezJesús Montoya-RamírezOmar Felipe Gaytán-FuentesRebeca Pérez-Cabeza de VacaMónica Escamilla-TilchJuan Antonio Pineda-JuárezMario Antonio Téllez-GonzálezPaul Mondragón-TeránMartha Eunice Rodríguez-ArellanoAlejandra Contreras-RamosSilvia GarcíaRolando Efraín Hernández-MuñozPublished in: The Journal of international medical research (2021)
The characteristics of adipose tissue and the circulating concentrations of markers of adipose pathology might represent useful predictors of the reduction in CVR following MS.Clinical trial registration number: NCT0356198 (https://clinicaltrials.gov).
Keyphrases
- adipose tissue
- clinical trial
- insulin resistance
- high fat diet
- minimally invasive
- mass spectrometry
- multiple sclerosis
- coronary artery bypass
- ms ms
- open label
- phase ii
- study protocol
- type diabetes
- metabolic syndrome
- double blind
- surgical site infection
- coronary artery disease
- acute coronary syndrome
- placebo controlled